WHO to rename monkeypox after scientists call it 'discriminating and stigmatizing'

World Health Organization Director-General Tedros Adhanom Ghebreyesus announced that the monkeypox virus is about to get a new name, following accusations of it being "discriminatory and stigmatizing," Time reported.
The swollen-lymph node-causing virus will be renamed after several global scientists pushed for the change, said WHO. The claims of discrimination stemmed from the false narrative about monkeypox being linked to Africa, which scientists outlined in a letter published on June 10.
In their letter, the researchers argued that "[t]he most obvious manifestation of this is the use of photos of African patients to depict the pox lesions in mainstream media in the global north."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
One spokesperson added that the current name was not within the guidelines of the organization. Despite the virus being named in 1958 when it was first identified "in colonies of monkeys," People explains there are still geographical areas and animal names that WHO recommends avoiding.
The symptoms of the virus include fever, headache, muscle aches, chills, and fatigue followed by a rash that spreads from the face to other body parts — and typically is contracted by direct contact with bodily fluids. The death rate in Congo is about 1 in 10 people who catch it, whereas, in the United States, no one has died from monkeypox. Back in 2003, the U.S. saw "an outbreak with 47 cases," the Centers for Disease Control and Prevention reported.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelsee Majette has worked as a social media editor at The Week since 2022. In 2019, she got her start in local television as a digital producer and fill-in weather reporter at NTV News. Kelsee also co-produced a lifestyle talk show while working in Nebraska and later transitioned to 13News Now as a digital content producer.
-
US foodies brace for tariff war
Under The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
By Chas Newkey-Burden, The Week UK Published
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published